In the coronavirus disease (COVID-19) pandemic, cancer patients could be a high-risk group due to their immunosuppressed status; therefore, data on cancer patients must be available in order to consider the most adequate strategy of care. We carried out a cohort study on the risk of hospitalization for COVID-19, oncological history, and outcomes on COVID-19 infected cancer patients admitted to the Hospital of Reggio Emilia. Between 1 February and 3 April 2020, a total of 1226 COVID-19 infected patients were hospitalized. The number of cancer patients hospitalized with COVID-19 infection was 138 (11.3%). The median age was slightly higher in patients with cancers than in those without (76.5 vs. 73.0). The risk of intensive care unit (ICU) admission (10.1% vs. 6.7%; RR 1.23, 95% Confidence Interval (CI) 0.63–2.41) and risk of death (34.1% vs. 26.0%; RR 1.07, 95% CI 0.61–1.71) were similar in cancer and non-cancer patients. In the cancer patients group, 89/138 (64.5%) patients had a time interval >5 years between the diagnosis of the tumor and hospitalization. Male gender, age > 74 years, metastatic disease, bladder cancer, and cardiovascular disease were associated with mortality risk in cancer patients. In the Reggio Emilia Study, the incidence of hospitalization for COVID-19 in people with previous diagnosis of cancer is similar to that in the general population (standardized incidence ratio 98; 95% CI 73–131), and it does not appear to have a more severe course or a higher mortality rate than patients without cancer. The phase II of the COVID-19 epidemic in cancer patients needs a strategy to reduce the likelihood of infection and identify the vulnerable population, both in patients with active antineoplastic treatment and in survivors with frequently different coexisting medical conditions.
Sars-cov-2 positive hospitalized cancer patients during the italian outbreak: The cohort study in reggio emilia / Pinto, C.; Berselli, A.; Mangone, L.; Damato, A.; Iachetta, F.; Foracchia, M.; Zanelli, F.; Gervasi, E.; Romagnani, A.; Prati, G.; Lui, S.; Venturelli, F.; Vicentini, M.; Besutti, G.; De Palma, R.; Rossi, P. G.. - In: BIOLOGY. - ISSN 2079-7737. - 9:8(2020), pp. 1-13. [10.3390/biology9080181]
Data di pubblicazione: | 2020 | |
Data di prima pubblicazione: | 22-lug-2020 | |
Titolo: | Sars-cov-2 positive hospitalized cancer patients during the italian outbreak: The cohort study in reggio emilia | |
Autore/i: | Pinto, C.; Berselli, A.; Mangone, L.; Damato, A.; Iachetta, F.; Foracchia, M.; Zanelli, F.; Gervasi, E.; Romagnani, A.; Prati, G.; Lui, S.; Venturelli, F.; Vicentini, M.; Besutti, G.; De Palma, R.; Rossi, P. G. | |
Autore/i UNIMORE: | ||
Digital Object Identifier (DOI): | http://dx.doi.org/10.3390/biology9080181 | |
Rivista: | ||
Volume: | 9 | |
Fascicolo: | 8 | |
Pagina iniziale: | 1 | |
Pagina finale: | 13 | |
Codice identificativo ISI: | WOS:000564052800001 | |
Codice identificativo Scopus: | 2-s2.0-85088239781 | |
Codice identificativo Pubmed: | 32707770 | |
Citazione: | Sars-cov-2 positive hospitalized cancer patients during the italian outbreak: The cohort study in reggio emilia / Pinto, C.; Berselli, A.; Mangone, L.; Damato, A.; Iachetta, F.; Foracchia, M.; Zanelli, F.; Gervasi, E.; Romagnani, A.; Prati, G.; Lui, S.; Venturelli, F.; Vicentini, M.; Besutti, G.; De Palma, R.; Rossi, P. G.. - In: BIOLOGY. - ISSN 2079-7737. - 9:8(2020), pp. 1-13. [10.3390/biology9080181] | |
Tipologia | Articolo su rivista |
File in questo prodotto:
Pubblicazioni consigliate

I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris